Abstract Details

Title Effects of Switching from Duloxetine to Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Study in Fibromyalgia

Topic Ethics, Pain and Palliative Care

Presentation(s) (-)

Poster/Presentation
Number 271

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Cameron Brennan	Cameron Brennan has nothing to disclose.
	No disclosure on file
	No disclosure on file
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Kimberley M. Thacker, MD	No disclosure on file
	No disclosure on file

��ɫ��